MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-HR-05-0071369
Imperial Life Sciences Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹76.2 Cr
▲ 28% YoY
Net profit · FY 2025
₹11.97 Cr
Net margin 15.7%
EBITDA · FY 2025
₹16.36 Cr
EBITDA margin 21.5%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹54.3 Cr
Satisfied ₹50 Lakh
Company age
20 yrs
Est. 2006
Employees · EPFO
68
Provident fund records
About Imperial Life Sciences Private Limited
Data last updated:
Imperial Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 17 June 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33125DL2006PTC149810. Its GSTIN is 06AABCI5252Q1Z8 (Haryana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Suresh Kumar Gupta and Neeraj Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 234 Somdutt Chamber – II 9 Bhikaji Cama Place, New Delhi, Delhi, India – 110066.
As per the financials filed for FY 2025, the company reported a revenue of ₹76.2 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹11.97 Cr (net margin 15.7%) and EBITDA of ₹16.36 Cr (EBITDA margin 21.5%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 4% over five years.
The company has about 68 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹54.3 Cr and satisfied charges of ₹50 Lakh on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 1 case is pending. The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹41 Lakh; the latest was in March 2013. Its 6 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 3 smaller; the largest is Iza Medi Technologies Private Limited with revenue of ₹78.81 Cr.
Imperial Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0071369). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website imperialls.com.
Company details
CIN U33125DL2006PTC149810
Registration Number 149810
Incorporation Date 17 June 2006
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HR-05-0071369
Recognitions & Rankings of Imperial Life Sciences
Contact details
Imperial Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its website is imperialls.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat No. 234 Somdutt Chamber – II 9 Bhikaji Cama Place, New Delhi, Delhi, India – 110066
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Imperial Life Sciences Private Limited, buy the company report.
Comprehensive company report
Imperial Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Imperial Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Imperial Life Sciences Private Limited, buy the company report.
Financials of Imperial Life Sciences Private Limited
FY 2025 filings availableImperial Life Sciences Private Limited reported revenue of ₹76.2 Cr (up 28% YoY) for FY 2025.
Revenue · FY 2025
₹76.2 Cr ▲ 28%
Net profit · FY 2025
₹11.97 Cr margin 15.7%
EBITDA · FY 2025
₹16.36 Cr margin 21.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▼ 31%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▲ 622%
3 years · compounded
▲ 2%
5 years · compounded
▲ 28%
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 28% growth in the latest year. EBITDA rose 622% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.36 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.97 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.5% | ||||
| Net Profit Margin | 15.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Imperial Life Sciences Private Limited, buy the company report.
Board of directors of Imperial Life Sciences Private Limited
Imperial Life Sciences has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Kumar Gupta | Director | 17 Jun 2006 | 20 Years 4 Months | Current |
| Neeraj Gupta | Director | 17 Jun 2006 | 20 Years 4 Months | Current |
| Prem Lata Gupta Also directs: Imperial Biomedic Pvt Ltd | Director | 17 Jun 2006 | 20 Years 4 Months | Current |
| Ritu Gupta Also directs: Genes 2Me Private Limited, Ils Foundation | Director | 04 Jan 2014 | 12 Years 9 Months | Current |
Peer comparison
Imperial Life Sciences Private Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Iza Medi Technologies Private Limited | ₹78.81 Cr (FY 2025) | 10.0% | Hyderabad, Telangana, India | |||
| Schulke India Private Limited | ₹76.85 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Pushpa Sales Private Limited | ₹76.58 Cr (FY 2025) | 1.0% | Lucknow, Uttar Pradesh, India | |||
| Imperial Life Sciences Private Limitedthis company | ₹76.2 Cr (FY 2025) | ₹11.97 Cr | 15.7% | 28.0% | 68 | New Delhi, Delhi, India |
| Cvi Contact Lens India Private Limited | ₹74.53 Cr (FY 2025) | 16.0% | Mumbai, Maharashtra, India | |||
| Kanlife India Private Limited | ₹74.49 Cr (FY 2024) | 49.0% | Bangalore, Karnataka, India | |||
| Nibso Metals Pvt Ltd | ₹74.4 Cr (FY 2024) | 25.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Imperial Life Sciences Private Limited, buy the company report.
Auditor
Imperial Life Sciences Private Limited is audited by K.S BAWA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.S BAWA & ASSOCIATES | FY 2023 | 003979N |
Shareholding
The shareholding of Imperial Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Imperial Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹54.3 Cr
Satisfied charges
₹50 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Aug 2024 | 100990811 | Hdfc Bank Limited | ₹2.1 Cr | Open | |
| 08 Feb 2024 | 100877527 | Others | ₹11.63 Cr | Open | |
| 29 Mar 2021 | 100462420 | Axis Bank Limited | ₹14 Cr | Open | |
| 30 Nov 2019 | 100306735 | Others | ₹70 Lakh | Open | |
| 30 Nov 2019 | 100307140 | Others | ₹2 Cr | Open |
To see the full charge records of Imperial Life Sciences Private Limited, buy the company report.
Total charge records: 13 View all charges
Deals & funding
Imperial Life Sciences Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹41 Lakh; the latest was in March 2013.
Total deals
3
Funding rounds
2
Secondary share transfer
1
Disclosed funding
₹41 Lakh
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2011 | Funding round | ₹25 Lakh | Investors: 3 individuals |
| Dec 2008 | Funding round | ₹16 Lakh | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Imperial Life Sciences Private Limited has 3 court cases on record: 2 filed by Imperial Life Sciences, 1 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed by the company
2
Filed against the company
1
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 1 | 1 |
| District courts | 1 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gurugram, Haryana | Cheque dishonour complaint | Filed by the company against International Recreation and Amusement Ltd and 1 other | Disposed |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against The State of Ap and 3 others | Pending |
| Allahabad High Court | Arbitration matter | Filed against the company by an individual | Disposed |
To see the full case history of Imperial Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Imperial Life Sciences Private Limited was last rated by Crisil on 22 Oct 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 22 Oct 2019 |
To see the full credit ratings and regulatory alerts of Imperial Life Sciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Imperial Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Imperial Life Sciences Private Limited has a workforce of 68 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
68
Active EPFO establishments
1
Employee growth
-2.86%
GST
Imperial Life Sciences has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AABCI5252Q1Z8 | Haryana | Active | 01 Jul 2017 |
| 03AABCI5252Q1ZE | Punjab | Active | 01 Jun 2018 |
To see the full GST registrations and return filing status of Imperial Life Sciences Private Limited, buy the company report.
Recent activity
Imperial Life Sciences Private Limited has 5 board changes on record since 2006: 4 appointments and 1 cessation. The latest: Ritu Gupta ceased to be Additional Director on 30 Sep 2019.
AGM
Imperial Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Imperial Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others of Rs. 1,162.50 Lakh registered on 08 Feb 2024 with Charge ID 100877527 was modified on 09 Sep 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 210.00 Lakh with Charge ID 100990811 was registered on 21 Aug 2024.
Charges
A charge with Others amounted to Rs. 1,162.50 Lakh with Charge ID 100877527 was registered on 08 Feb 2024.
Charges
A charge with Axis Bank Limited of Rs. 1,400.00 Lakh registered on 29 Mar 2021 with Charge ID 100462420 was modified on 10 Jul 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 1,400.00 Lakh with Charge ID 100462420 was registered on 29 Mar 2021.
Charges
A charge with Others amounted to Rs. 70.00 Lakh with Charge ID 100306735 was registered on 30 Nov 2019.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 100307140 was registered on 30 Nov 2019.
Ceased
Ritu Gupta ceased to be Additional Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 49.42 Lakh with Charge ID 100286682 was registered on 14 Aug 2019.
Charges
A charge with Others of Rs. 1,400.00 Lakh registered on 11 Sep 2009 with Charge ID 10177503 was modified on 14 Dec 2018.
13 earlier events are in the company report.
Frequently asked questions
Imperial Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 17 June 2006 (20+ years old) and is registered under CIN U33125DL2006PTC149810.
Imperial Life Sciences has 4 current directors:
- Suresh Kumar Gupta - Director
- Neeraj Gupta - Director
- Prem Lata Gupta - Director
- Ritu Gupta - Director
The latest financial statements of Imperial Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Imperial Life Sciences is 06AABCI5252Q1Z8, registered in Haryana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 03AABCI5252Q1ZE (Punjab).
The CIN (Corporate Identification Number) of Imperial Life Sciences is U33125DL2006PTC149810. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Imperial Life Sciences has 3 court cases on record: 2 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Imperial Life Sciences was incorporated on 17 June 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
Imperial Life Sciences has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹41 Lakh; the latest was in March 2013.
The peers of Imperial Life Sciences by revenue are Iza Medi Technologies Private Limited, Schulke India Private Limited, Pushpa Sales Private Limited, Cvi Contact Lens India Private Limited, Kanlife India Private Limited and 1 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Ritu Gupta ceased to be Additional Director on 30 Sep 2019. Ritu Gupta was appointed as Director on 04 Jan 2014. Neeraj Gupta was appointed as Director on 17 Jun 2006. Imperial Life Sciences has 5 board changes on record in total.
Yes, Imperial Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-HR-05-0071369).